IRIS Accounts Production v24.1.0.578 11511200 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false false true false 4556 7078 1284 8222 9650 5700 12922 4556 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh115112002022-12-31115112002023-12-31115112002023-01-012023-12-31115112002021-12-31115112002022-01-012022-12-31115112002022-12-3111511200ns15:EnglandWales2023-01-012023-12-3111511200ns14:PoundSterling2023-01-012023-12-3111511200ns10:Director12023-01-012023-12-3111511200ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3111511200ns10:SmallEntities2023-01-012023-12-3111511200ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3111511200ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3111511200ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3111511200ns10:FullAccounts2023-01-012023-12-311151120012023-01-012023-12-311151120041ns10:Director12022-12-311151120041ns10:Director12021-12-311151120041ns10:Director12023-01-012023-12-311151120041ns10:Director12022-01-012022-12-311151120041ns10:Director12023-12-311151120041ns10:Director12022-12-3111511200ns10:Director22023-01-012023-12-3111511200ns10:RegisteredOffice2023-01-012023-12-3111511200ns5:CurrentFinancialInstruments2023-12-3111511200ns5:CurrentFinancialInstruments2022-12-3111511200ns5:ShareCapital2023-12-3111511200ns5:ShareCapital2022-12-3111511200ns5:RetainedEarningsAccumulatedLosses2023-12-3111511200ns5:RetainedEarningsAccumulatedLosses2022-12-3111511200ns5:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3111511200ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-12-3111511200ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-01-012023-12-3111511200ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-12-3111511200ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-12-3111511200ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3111511200ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3111511200ns10:Director222022-12-3111511200ns10:Director222021-12-3111511200ns10:Director222023-01-012023-12-3111511200ns10:Director222022-01-012022-12-3111511200ns10:Director222023-12-3111511200ns10:Director222022-12-31
REGISTERED NUMBER: 11511200 (England and Wales)








UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

IN & OUT HEALTH LTD

IN & OUT HEALTH LTD (REGISTERED NUMBER: 11511200)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 December 2023




Page

Company information 1

Balance sheet 2

Notes to the financial statements 3


IN & OUT HEALTH LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 December 2023







DIRECTORS: Mrs C E Penniceard
Mr A M Penniceard





REGISTERED OFFICE: 41 Rodney Road
Cheltenham
Gloucestershire
GL50 1HX





REGISTERED NUMBER: 11511200 (England and Wales)





ACCOUNTANTS: Mitchell Glanville Limited
41 Rodney Road
Cheltenham
Gloucestershire
GL50 1HX

IN & OUT HEALTH LTD (REGISTERED NUMBER: 11511200)

BALANCE SHEET
31 December 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 8,227 3,440

CURRENT ASSETS
Debtors 5 598 88
Cash at bank - 23
598 111
CREDITORS
Amounts falling due within one year 6 25,792 17,667
NET CURRENT LIABILITIES (25,194 ) (17,556 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(16,967

)

(14,116

)

PROVISIONS FOR LIABILITIES 2,148 643
NET LIABILITIES (19,115 ) (14,759 )

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings (19,117 ) (14,761 )
(19,115 ) (14,759 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 July 2024 and were signed on its behalf by:





Mrs C E Penniceard - Director


IN & OUT HEALTH LTD (REGISTERED NUMBER: 11511200)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 December 2023

1. STATUTORY INFORMATION

In & Out Health Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

INTANGIBLE ASSETS
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of 4 years.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4. INTANGIBLE FIXED ASSETS
Development
costs
£   
COST
At 1 January 2023 4,128
Additions 7,095
At 31 December 2023 11,223
AMORTISATION
At 1 January 2023 688
Amortisation for year 2,308
At 31 December 2023 2,996
NET BOOK VALUE
At 31 December 2023 8,227
At 31 December 2022 3,440

IN & OUT HEALTH LTD (REGISTERED NUMBER: 11511200)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 December 2023

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Tax 477 -
Prepayments 121 88
598 88

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 4 -
Tax - 474
Other creditors 12,087 11,827
Directors' loan accounts 12,922 4,556
Accrued expenses 779 810
25,792 17,667

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 December 2023 and 31 December 2022:

2023 2022
£    £   
Mr A M Penniceard and Mrs C E Penniceard
Balance outstanding at start of year (4,556 ) (7,078 )
Amounts advanced 1,284 8,222
Amounts repaid (9,650 ) (5,700 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (12,922 ) (4,556 )

The loan from the directors' does not attract any interest and there is no specified repayment date.

8. RELATED PARTY DISCLOSURES

Included within other creditors is an amount of £12,087 (2023: £11,827) due to Penni Black Ldn Ltd. Penni Black Ldn Ltd is 100% owned by the directors' of the company.

9. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Mr and Mrs Penniceard.